TSX Venture Exchange Provides Relief to Issuers in Wake of COVID-19

Sandra L. SecordLitigation Group Partner, Torkin Manes LLP

On April 8, 2020, the TSX Venture Exchange (the “Exchange”) released a bulletin announcing that it was providing temporary relief from its minimum pricing guidelines for issuers in wake of the COVID-19 pandemic, reducing the minimum share issuance price from $0.05 to $0.01 in certain circumstances. The temporary relief went into effect immediately. This bulletin follows previous Exchange guidance and relief in the wake of COVID-19 that provided relief to issuers from certain timeframes respecting the holding of annual meetings and the approval of stock option plans.